Asahi Kasei Bids To Buy At Least Two-Thirds Of U.S.-Based Zoll Medical
This article was originally published in PharmAsia News
Executive Summary
Japan’s Asahi Kasei has offered to buy at least two-thirds of U.S.-based Zoll Medical for $93 a share, leading eventually to a total buyout by the Japan-based chemical manufacturer.